Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.
Yoshitaka MiyaokaNoriaki KuritaTadashi SofueHiroki NishiwakiMasahiro KoizumiSayaka ShimizuSho SasakiTakuji IshimotoTakehiko WadaPublished in: Clinical and experimental nephrology (2023)
RTX use for pMN is less common than for MCNS but not infrequent. Treatment with RTX was more frequent in biopsy-intensive facilities, and it was fully paid by the facility or patient in one-fifth of cases.